Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Buy
6,089
+2,653
+77% +$946K 0.19% 120
2025
Q4
$1.12M Sell
3,436
-26,088
-88% -$8.28M 0.07% 309
2025
Q3
$8.33M Buy
29,524
+25,905
+716% +$7.51M 0.44% 39
2025
Q2
$1.01M Sell
3,619
-25,709
-88% -$7.28M 0.06% 329
2025
Q1
$9.14M Sell
29,328
-1,572
-5% -$464K 0.57% 29
2024
Q4
$8.05M Buy
30,900
+226
+0.7% +$67.1K 0.51% 35
2024
Q3
$9.88M Buy
30,674
+22,462
+274% +$7.35M 0.63% 23
2024
Q2
$2.57M Buy
8,212
+478
+6% +$140K 0.3% 75
2024
Q1
$2.2M Buy
7,734
+813
+12% +$238K 0.23% 110
2023
Q4
$1.99M Buy
6,921
+2,397
+53% +$653K 0.23% 129
2023
Q3
$1.22M Sell
4,524
-3,364
-43% -$840K 0.14% 178
2023
Q2
$1.75M Buy
7,888
+3,535
+81% +$820K 0.21% 121
2023
Q1
$1.05M Sell
4,353
-2,483
-36% -$610K 0.14% 157
2022
Q4
$1.8M Buy
6,836
+87
+1% +$23.3K 0.23% 104
2022
Q3
$1.52M Buy
6,749
+241
+4% +$58.4K 0.21% 107
2022
Q2
$1.58M Buy
6,508
+259
+4% +$63.5K 0.21% 108
2022
Q1
$1.51M Sell
6,249
-112
-2% -$25.7K 0.17% 122
2021
Q4
$1.43M Buy
6,361
+1,749
+38% +$369K 0.15% 137
2021
Q3
$981K Buy
4,612
+122
+3% +$28.1K 0.11% 190
2021
Q2
$1.09M Sell
4,490
-707
-14% -$174K 0.12% 163
2021
Q1
$1.29M Sell
5,197
-133
-2% -$31.7K 0.17% 128
2020
Q4
$1.23M Sell
5,330
-156
-3% -$36K 0.17% 132
2020
Q3
$1.4M Sell
5,486
-219
-4% -$54.3K 0.24% 95
2020
Q2
$1.34M Sell
5,705
-939
-14% -$214K 0.25% 95
2020
Q1
$1.35M Buy
6,644
+2,049
+45% +$448K 0.32% 67
2019
Q4
$1.11M Sell
4,595
-1,133
-20% -$250K 0.21% 122
2019
Q3
$1.11M Buy
5,728
+2,487
+77% +$477K 0.21% 116
2019
Q2
$598K Sell
3,241
-144
-4% -$25.8K 0.13% 163
2019
Q1
$643K Buy
3,385
+69
+2% +$13.2K 0.14% 161
2018
Q4
$645K Sell
3,316
-169
-5% -$33K 0.16% 139
2018
Q3
$722K Buy
3,485
+95
+3% +$18.7K 0.15% 170
2018
Q2
$625K Buy
3,390
+548
+19% +$96.9K 0.13% 179
2018
Q1
$484K Sell
2,842
-574
-17% -$105K 0.08% 234
2017
Q4
$594K Buy
3,416
+673
+25% +$119K 0.13% 181
2017
Q3
$512K Sell
2,743
-117
-4% -$20.7K 0.16% 158
2017
Q2
$493K Sell
2,860
-14
-0.5% -$2.28K 0.14% 193
2017
Q1
$472K Sell
2,874
-15
-0.5% -$2.49K 0.14% 198
2016
Q4
$422K Sell
2,889
-7
-0.2% -$1.05K 0.13% 205
2016
Q3
$483K Sell
2,896
-15
-0.5% -$2.54K 0.15% 184
2016
Q2
$443K Buy
2,911
+99
+4% +$15.4K 0.14% 191
2016
Q1
$422K Sell
2,812
-382
-12% -$56.8K 0.13% 210
2015
Q4
$518K Sell
3,194
-12
-0.4% -$1.89K 0.15% 182
2015
Q3
$444K Buy
3,206
+101
+3% +$15.9K 0.13% 201
2015
Q2
$477K Buy
3,105
+432
+16% +$69.2K 0.13% 191
2015
Q1
$428K Buy
+2,673
New +$421K 0.11% 220

Other funds holding AMGN

Hilltop Holdings's AMGN Position: Q1 2026 in Review

Hilltop Holdings increased its Amgen (AMGN) stake by 77% in Q1 2026, buying an estimated $946K and bringing the position to 6,089 shares worth $2.14M. The position accounts for 0.19% of the portfolio, ranked #120.

Hilltop Holdings first reported a position in AMGN in Q1 2015 and has held it in 45 quarters since. The position peaked at $9.88M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hilltop Holdings held 6,089 shares of Amgen worth $2.14M as of Q1 2026.
  • Hilltop Holdings bought 2,653 Amgen shares in Q1 2026, an estimated $946K.
  • Amgen made up 0.19% of Hilltop Holdings's portfolio in Q1 2026, its #120 holding.
  • Hilltop Holdings first reported a position in Amgen in Q1 2015 and has held it in 45 quarters since.
  • Hilltop Holdings's Amgen position peaked at $9.88M in Q3 2024.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.